Chemomab Therapeutics (CMMB) Share-based Compensation (IS) (2018 - 2023)
Chemomab Therapeutics posted quarterly Share-based Compensation (IS) of $130000.0 for Q3 2023, down 84.45% year-on-year from $836000.0 in Q3 2022, and down 84.45% on a QoQ basis from $836000.0 in Q3 2022.
Chemomab Therapeutics (CMMB) has 4 years of Share-based Compensation (IS) data on file, last reported at $130000.0 in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (IS) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.45 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 14.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 130,000.00 |
| Sep 30, 2023 | 130,000.00 |
| Sep 30, 2022 | 836,000.00 |
| Sep 30, 2022 | 836,000.00 |
| Sep 30, 2019 | 321,000.00 |
| Sep 30, 2019 | 321,000.00 |
| Sep 30, 2018 | 281,000.00 |
| Sep 30, 2018 | 281,000.00 |